학술논문
Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML)
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:34-35
Subject
Language
ISSN
0006-4971